Literature DB >> 18054928

Propecia-induced spermatogenic failure: a report of two cases.

Kimberly E Liu1, Saleh Binsaleh, Kirk C Lo, Keith Jarvi.   

Abstract

OBJECTIVE: To describe the results of two cases of azoospermia and severe oligospermia in men during and after cessation of finasteride 1 mg.
DESIGN: Case report.
SETTING: Tertiary-care hospital-based clinic for andrology/male infertility. PATIENT(S): Two patients with azoospermia and severe oligospermia using finasteride 1 mg for hair loss. INTERVENTION(S): Discontinuation of finasteride. MAIN OUTCOME MEASURE(S): Improvement in sperm concentration. RESULT(S): Patient A had documented azoospermia over 1 year and was initially booked for a testicular biopsy. Six months after discontinuation of finasteride 1 mg daily he showed improvement in sperm concentration to 5.5 x 10(6)/mL. Patient B had severe oligospermia with a sperm concentration of 4 x 10(6)/mL. Sperm concentration improved to 6.6 then 18.7 x 10(6)/mL at 3 and 6 months after stopping finasteride. CONCLUSION(S): We report two cases of infertile patients with azoospermia or severe oligospermia who showed significant improvements in sperm concentrations 6 months after the discontinuation of finasteride. In one case, improvement in semen parameters prevented the need for testicular biopsy and corrected the azoospermia. Stopping finasteride in the infertility population may improve semen parameters, and may allow for less invasive fertility treatments.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18054928     DOI: 10.1016/j.fertnstert.2007.08.026

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  9 in total

1.  Clomiphene citrate rescue of spermatogenesis in men with infertility while remaining on finasteride: A case report.

Authors:  Christopher Wu; Ellen Forbes; Keith Allen Jarvi
Journal:  Can Urol Assoc J       Date:  2017-03-16       Impact factor: 1.862

Review 2.  Androgenetic Alopecia: An Update of Treatment Options.

Authors:  Yanna Kelly; Aline Blanco; Antonella Tosti
Journal:  Drugs       Date:  2016-09       Impact factor: 9.546

3.  How to Deal with the Issues of Fertility, Malignancies, and the Postfinasteride Syndrome while Prescribing Finasteride for Male Pattern Hair Loss.

Authors:  Ralph M Trüeb; Ngoc-Nhi Catharina Luu; Maria Fernanda Reis Gavazzoni Dias; Hudson Dutra Rezende
Journal:  Skin Appendage Disord       Date:  2022-01-10

4.  Paternal Finasteride Treatment Can Influence the Testicular Transcriptome Profile of Male Offspring-Preliminary Study.

Authors:  Agnieszka Kolasa; Dorota Rogińska; Sylwia Rzeszotek; Bogusław Machaliński; Barbara Wiszniewska
Journal:  Curr Issues Mol Biol       Date:  2021-07-31       Impact factor: 2.976

Review 5.  The Impact of 5α-Reductase Inhibitor Use for Male Pattern Hair Loss on Men's Health.

Authors:  Mohammed A Said; Akanksha Mehta
Journal:  Curr Urol Rep       Date:  2018-06-16       Impact factor: 3.092

6.  Secondary infertility due to use of low-dose finasteride.

Authors:  Ahmet Şalvarci; Okan Istanbulluoğlu
Journal:  Int Urol Nephrol       Date:  2012-10-16       Impact factor: 2.370

Review 7.  Finasteride in Hidradenitis Suppurativa: A "Male" Therapy for a Predominantly "Female" Disease.

Authors:  Birgit N Khandalavala; Melissa Voutsalath Do
Journal:  J Clin Aesthet Dermatol       Date:  2016-06-01

8.  Finasteride and male fertility.

Authors:  Dilip Gude
Journal:  J Hum Reprod Sci       Date:  2011-05

9.  Connexin 43 expression in the testes during postnatal development of finasteride-treated male rat offspring.

Authors:  Agnieszka Kolasa-Wołosiuk; Kamila Misiakiewicz-Has; Irena Baranowska-Bosiacka; Izabela Gutowska; Maciej Tarnowski; Marta Tkacz; Barbara Wiszniewska
Journal:  Arch Med Sci       Date:  2016-11-15       Impact factor: 3.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.